Pages that link to "Q34312878"

The following pages link to Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. (Q34312878):

Displaying 36 items.

• Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus (Q24597687) (← links)
• Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity (Q24650317) (← links)
• Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors (Q28270337) (← links)
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ (Q28298445) (← links)
• The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum (Q28587112) (← links)
• Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain (Q30497569) (← links)
• Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (Q30609922) (← links)
• Endocannabinoids in the dentate gyrus (Q33757950) (← links)
• Fatty acid amide hydrolase deficiency limits early pregnancy events (Q34872765) (← links)
• Molecular composition of the endocannabinoid system at glutamatergic synapses. (Q35220762) (← links)
• Cannabinoid receptors and endocannabinoids: evidence for new players. (Q35594830) (← links)
• Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation (Q35688747) (← links)
• Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission (Q35839753) (← links)
• CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. (Q36371600) (← links)
• Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. (Q36887138) (← links)
• The pharmacology of the cannabinoid system--a question of efficacy and selectivity (Q36977738) (← links)
• Excitatory afferents to CA3 pyramidal cells display differential sensitivity to CB1 dependent inhibition of synaptic transmission. (Q37030616) (← links)
• Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy (Q37045477) (← links)
• Signaling via CNS cannabinoid receptors (Q37109008) (← links)
• The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. (Q37142233) (← links)
• Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). (Q37226537) (← links)
• Endocannabinoid signaling in microglial cells (Q37250243) (← links)
• Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands (Q37277605) (← links)
• Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity (Q37307823) (← links)
• The therapeutic potential of novel cannabinoid receptors (Q37402927) (← links)
• CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations (Q37648995) (← links)
• Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas (Q37752096) (← links)
• Signal peptide and denaturing temperature are critical factors for efficient mammalian expression and immunoblotting of cannabinoid receptors (Q41976757) (← links)
• The endocannabinoid system controls key epileptogenic circuits in the hippocampus (Q42065383) (← links)
• Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS-PDC phenotype. (Q42110799) (← links)
• ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta9-tetrahydrocannabinol exposure. (Q42495900) (← links)
• Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells (Q46075930) (← links)
• Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. (Q48523125) (← links)
• Differences in hippocampal protein levels between C57Bl/6J, PWD/PhJ, and Apodemus sylvaticus are paralleled by differences in spatial memory (Q51039723) (← links)
• Modular competition driven by NMDA receptor subtypes in spike-timing-dependent plasticity. (Q51924125) (← links)
• Δ9-tetrahydrocannabinol: Drug discrimination abuse liability testing in female Lister Hooded rats: Trials, tribulations and triumphs (Q100954811) (← links)